{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:43:30Z","timestamp":1783521810758,"version":"3.55.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hip structural analysis (HSA) is a method for evaluating bone geometry reflecting bone structural and biomechanical properties. However, tissue-selective estrogen complex (TSEC) treatment effects on HSA have not been investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study was performed to evaluate the effect of TSEC treatment on hip geometry in postmenopausal Korean women. The treatment was given for 12 months, and hip geometry was measured by HSA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A total of 40 postmenopausal women who received TSEC containing conjugated estrogen 0.45 mg and bazedoxifene 20 mg for treating vasomotor symptoms were included in this retrospective cohort study. The changes in bone mineral density and parameters of HSA including the outer diameter, cross-sectional area, cross-sectional moment of inertia, cortical thickness, section modulus, and buckling ratio as determined by dual-energy X-ray absorptiometry were compared before and after 12 months of TSEC treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean age and years since menopause were 55.1 and 4.5 years, respectively. Total hip bone mineral density significantly increased by 0.74% after treatment (P=0.011). The changes in HSA were mainly demonstrated in the narrow femoral neck: cross-sectional area (P=0.003) and cortical thickness (P&amp;lt;0.001) increased significantly. For the shaft region, only SM decreased significantly after treatment (P=0.009). However, most parameters did not change significantly with TSEC treatment in the intertrochanteric and shaft regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings demonstrate that 12 months of TSEC treatment could improve bone geometry as measured by HSA. The findings suggest that TSEC might be an interesting option for the prevention of fracture as well as osteoporosis in postmenopausal women.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.649952","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T06:53:41Z","timestamp":1615445621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Tissue-Selective Estrogen Complex on Hip Structural Geometry in Postmenopausal Women: A 12-Month Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Bo Mi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DooSeok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS Recommendations on women\u2019s midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2012.717994","article-title":"Effects of bazedoxifene\/conjugated estrogens on endometrial safety and bone in postmenopausal women","volume":"16","author":"Mirkin","year":"2013","journal-title":"Climacteric"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1707","article-title":"Effects of bazedoxifene\/conjugated estrogens on the endometrium and bone: a randomized trial","volume":"99","author":"Pinkerton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol HSMetab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.060312","article-title":"Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women\u2019s health initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"J Bone Miner Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0021-9290(84)90010-1","article-title":"Non-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry","volume":"17","author":"Martin","year":"1984","journal-title":"J Biomech"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2015.06.006","article-title":"Measurement of Hip Geometry-Technical Background","volume":"18","author":"Beck","year":"2015","journal-title":"J Clin Densitom"},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3803\/EnM.2016.31.1.25","article-title":"Dual-Energy X-Ray Absorptiometry: Beyond Bone Mineral Density Determination","volume":"31","author":"Choi","year":"2016","journal-title":"Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070712","article-title":"Femoral Neck BMD Is a Strong Predictor of Hip Fracture Susceptibility in Elderly Men and Women Because It Detects Cortical Bone Instability: The Rotterdam Study","volume":"22","author":"Rivadeneira","year":"2007","journal-title":"J Bone Miner Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080802","article-title":"Prediction of Incident Hip Fracture Risk by Femur Geometry Variables Measured by Hip Structural Analysis in the Study of Osteoporotic Fractures","volume":"23","author":"Kaptoge","year":"2008","journal-title":"J Bone Miner Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1056-1","article-title":"Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density","volume":"21","author":"LaCroix","year":"2010","journal-title":"Osteoporos Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000694","article-title":"Effect of conjugated estrogens\/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials","volume":"23","author":"Gallagher","year":"2016","journal-title":"Menopause"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.04.027","article-title":"The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis","volume":"77","author":"Beck","year":"2015","journal-title":"Bone"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.11.2103","article-title":"Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures","volume":"16","author":"Beck","year":"2001","journal-title":"J Bone Miner Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050508","article-title":"Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial","volume":"20","author":"Greenspan","year":"2005","journal-title":"J Bone Miner Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080707","article-title":"Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women\u2019s Health Initiative hormone intervention trials","volume":"23","author":"Chen","year":"2008","journal-title":"J Bone Miner Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.maturitas.2007.04.012","article-title":"Postmenopausal HRT and tibolone in relation to muscle strength and body composition","volume":"58","author":"Jacobsen","year":"2007","journal-title":"Maturitas"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.649952\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T06:53:43Z","timestamp":1615445623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.649952\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":21,"alternative-id":["10.3389\/fendo.2021.649952"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.649952","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"article-number":"649952"}}